Cargando…
Incorporating risk preferences of patients in the valuation of immune checkpoint inhibitors for non-small cell lung cancer
Immunotherapy offers a distinctive mechanism of action compared to traditional treatments, arising from additional value dimensions that may not be captured in standard health technology assessments. Cancer patients may have the expectation that immunotherapy provides durable, long-term survival gai...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032401/ https://www.ncbi.nlm.nih.gov/pubmed/36969040 http://dx.doi.org/10.3389/fonc.2023.1027659 |